WHY ATTEND
The Life Science Strategy Summit on IP & Exclusivity is returning to Munich this October. The premier life science IP event, we're gathering the leading legal professionals working in biopharma for 3 days practical discussion on practical and industry-led patent strategy, patent prosecution and market exclusivity topics.
The first meeting following the launch of the Unified Patent Court (UPC), join the leading community of life science patent professionals to understand the industry’s reaction to the new court system and have candid discussions with the European life science intellectual property experts.
New for 2023 - The Global SPC & PTE Forum 2023
Join this one-day event and understand the key legislative changes and case law regarding SPC and PTE protection in Europe and beyond.
HIGHLIGHTS INCLUDE
- Cross-industry end-user panel discussing the opening of the UPC and the life science industry response with Chr. Hansen and IFF alongside a judicial perspective with 4 legal judges and 3 technical judges.
- IP Minds Roundtable discussions on: Antibody Case Law, Biosimilar IP Considerations, Arrow Declaration, Clinical Trials and Patent Strategy, AI and Life Science Patents, Trade Secrets vs Patent Protection, FTO: Best Practices
- 1-day dedicated event on SPCs entitled: Global SPC & PTE Forum 2023 with speakers from the European Commission, a Pan-European Patent Office Panel, the EPO, MSD, Polpharma Group and Adalvo
- Build a practical Exclusivity Strategy and understand the upcoming changes from the European Commission with speakers from Venable, Alkermes, Pieris Pharmaceuticals, BioNTech and Adalvo
SPC AND PTE FORUM 2023 (9TH OCTOBER)
Supplementary Protection Certificate's (SPCs) and Patent Term Extensions (PTEs) are a fundamental way in which European law compensates biopharmaceutical companies for their loss in exclusivity rights over a 20-year patent period. This exclusive event workshop will bring together the leading in-house counsel, private practitioners
Discover the latest trends and case studies within European SPC law and understand how this will affect your IP strategy and regulators to discuss the leading trends within SPC/PTE trends from filing to litigation.
PART 1
- Discover the latest trends and case studies within European SPC law and understand how this will affect your IP strategy
PART 2
- Understand the proposed changes to SPCs under the new UPC system and analyse whether a unitary SPC can be utilised
PART 3
- Learn from a wider discussion of PTE extension trends in USA, China, South Korea and Japan
FIND OUT MORE ABOUT THIS YEARS SUMMIT ON OUR NEW AGENDA
We're excited to be returning to Munich this year to review the latest Regulatory Exclusivity Strategies and legal challenges for pharmaceutical, biotech & medical device companies.
Fill out this short form to view the full 2023 agenda and find out more about how to get invovled
From time to time, we would like to contact you about our products and services, as well as other content that may be of interest to you. If you consent to us contacting you for this purpose, please tick above.
Subject Access Requests: If you would like a copy of the data/information we hold about you, please email [email protected].
User Deletion Request: If you wish to have your information that is held by Kisaco Research deleted, please email [email protected].
For more information on Kisaco Research policy and procedures, please visit our Privacy Policy.
By clicking submit below, you consent to allow Kisaco Research to store and process the personal information submitted above to provide you the content requested.
ACCESS THE AGENDA HERE
LIFE SCIENCES STRATEGY SUMMIT 2023 COMMUNITY
From our advisory board and speakering faculty to our media and strategic partners, our series wouldn't be possible without the contributions of Our esteemed community of in-house IP counsel, private practice and regulatory leaders.
2023 SPEAKERS

Gemma Campabadal

Ina Burck

John Kirkland

Thomas Boehmer

Cecile Teles
Cecile is Head Patent Attorney at Zentiva. She has over a decade of experience in the pharmaceutical industry.
Cecile is uniquely experienced and knowledgeable in the pharma space as she has experience in-house at an elite innovator company (Sanofi), biologics (Merck Serono), and extensive generic experience she gained as Zentiva.
Cecile is an enthusiastic manager of her team and was a key member of the IP team in leading the transformation of Zentiva into an independent and competitive generic company after divestment from Sanofi.
Cecile is a qualified European Patent Attorney. She also holds a certificate from CEIPI in patent litigation and most recently completed her diploma as a Master of Laws in France.

Jiri Slavik

Kora Knuchel

Bea Mcdonald

Shota Ueno

Sean Alexander
Sean Alexander is a qualified European Patent Attorney as well as a Canadian and U.S. Patent Agent. He has worked in the IP field for many years and is currently the Head of IP Strategy (H&N) for Chr. Hansen in Denmark. Prior to joining Chr. Hansen, Sean headed the IP team at Elanco Inc. based in the Netherlands and was a Partner with Gowling WLG in Canada. Sean has been recognized as one of the world's leading IP strategists by IAM Magazine and is regularly praised for his pragmatic and commercially aware approach to IP.

James Hogan

Fredrik Fredh
Fredrik is a qualified European Patent Attorney and experienced international IP strategist. Having completed academic studies of innovation and entrepreneurship processes, as well as IP law and management, he has a good grasp of various intellectual property rights (IPR).
Thanks to his many years as IP professional in the Pharma and Biotech industry, Fredrik has learnt to use this IPR toolbox to pursue his professional passion; maximizing return on investment for innovation.”

Jenny Davies
Jenny Davies is a life sciences and patent specialist with a Masters in Biochemistry from Oxford. She provides strategic advice to help clients protect and exploit their R&D investment in the life sciences sector, medical device sector and the chemical industry. Her work regularly entails negotiating agreements to support her clients' research, development, manufacture and commercialisation, and protect their markets through the enforcement of patents.
Jenny delivers business-focused solutions across her unique practice area spanning patents and dispute resolution, transactions ranging from strategic licensing to highly complex collaborations and regulatory matters. She advises clients in all aspects of patent enforcement, from technical analysis and global strategy to leading UK litigation and EPO oppositions.
Given the commercial and practical value of the assets Jenny protects, her approach combines precision and detail with a commercial mindset and sector-led solutions. Clients praise her "endless determination", "formidable intellect" and are "deeply impressed" with her "unusual capacity to think creatively".
Her work highlights include leading ground-breaking patent litigation up to the UK Court of Appeal to achieve a novel form of "Arrow declaration" for Fujifilm Kyowa Kirin and advising AstraZeneca across a range of high value and complex transactions: its collaboration with the University of Oxford (COVID-19 vaccine); two $6 billion oncology collaborations with Daiichi Sankyo; an $8.5 billion oncology deal with Merck; and a $300 million oncology deal with Genzyme (Caprelsa).
Jenny is a member of the BioIndustry Association's IP Advisory Committee, and SPC and exclusivities committee, and a regular speaker on patent litigation and strategy.

Kit Carter

Ha Kung Wong
Ha Kung Wong has over 20 years of experience practicing general intellectual property law with an emphasis on complex patent and trade secret litigation as well as IP transactions and contract negotiations for mergers, acquisitions, and collaborations in pharmaceuticals, biologics, and chemistry. Cases Mr. Wong has litigated include those related to proton pump inhibitors, allergy eye drops, anti-epileptic drugs, anti-tussive, injectable microspheres, RNAi products, and other pharmaceuticals. Mr. Wong also has extensive experience with Inter Partes Review, Post Grant Review, intellectual property counseling, pharmaceutical regulatory counseling, pre-suit investigations, licensing, and due diligence.
Mr. Wong has his BS with high distinction in Chemistry and his BS in Biochemistry from the University of Illinois Urbana-Champaign and his JD, cum laude, from the University of Notre Dame. Mr. Wong is currently an elected member of the Venable Board, is an Advisory Board Member for the Center for Biosimilars, is Treasurer, Executive Committee member, and Board Trustee for the Foundation for Advancement of Diversity in IP Law (FADIPL) and serves as faculty for the National Institute of Trial Advocacy (NITA) and Lawline.

Karin Pramberger
Karin has been Intellectual Property Director at the Polpharma Group since April 2018. She is responsible for all patent and trade mark related activities. Prior to joining the Polpharma Group, Karin was Head of IP of Medichem, Spain, and worked in various positions within the patent department of Teva, Barr and Pliva. She spent 7 years in a law firm in Vienna, Austria, where she became European and Austrian patent and trade mark attorney. She studied Biotechnology in Vienna, Austria, and at the Ecole Nationale Supérieure de Chemie de Paris, France. In 2017 she graduated with an LLB from the University of London. Since 2005 she has been a tutor at CEIPI, University of Strasbourg, for the pre-exam and the C-part of the European Qualifying Exam.

Paul Inman
With more than 25 years' experience of litigating intellectual property (IP) disputes both within the UK and internationally, Paul Inman works with companies ranging from small start-ups to major multi-national corporations. He specialises in the life sciences sector, which includes acting on high-profile pharmaceutical patent infringement cases in the UK Patents Court.
Paul provides life science businesses with commercial advice from an international outlook. His specialist experience ideally places him to provide this expertise and client care, with the ultimate aim of delivering well-rounded advice and guidance to ensure the best possible outcome.
As well as litigating in the English courts, he has co-ordinated and advised on IP and regulatory litigation matters across the globe; from all over Europe and the US, to as far afield as Asia, South Africa, Australia and New Zealand.
Successfully guiding clients through the maze of litigation is where Paul's strength lies, having now been involved over 25 years of litigation in cases leading to more than 40 reported judgments. These range from the tribunals of the UK Patent Office up to the House of Lords, European Patent Office and European Court of Justice.
Paul also has a degree in Molecular Biology and Biochemistry and during his professional career has established an outstanding reputation in the market. He is distinguished in the 2023 edition of IAM Patent 1000: The World's Leading Patent Professionals, ranked individually for both IP law and life sciences law in the peer review publication 'Best Lawyers® in the UK' and recognised in several categories within Chambers & Partners UK 2023.

Rian Kalden

Matthias Zigann

Dr Oliver Werner

Dr Martijn de Lange

Roberto Romandini
Roberto Romandini obtained his law degree from the University of Pisa and his LL.M. degree from the University of Munich, where he specialized in patent law. He completed his Ph.D. thesis on the patentability of human stem cells at the Max Planck Institute in Munich before practicing IP law at a leading IP law firm in Milan for 5 years. From 2013 he was a Senior Research Fellow at the Max Planck Institute for Innovation and Competition in Munich. Since 2019 he has been a legal member at the Boards of Appeal at the EPO.

Tobias Pichlmaier

Ronny Thomas

Dolores Cassidy
Dolores Cassidy, B.Sc. Ph.D., graduated from University College Dublin with a Ph.D. in Physical Chemistry. In 1998 she joined the Intellectual Property Office of Ireland as a Patent Examiner, with particular responsibility for the examination of Supplementary Protection Certificates (SPCs). In 2021 she was promoted to the position of Head of Patent/SPC Examination at the Irish Office.

Lena Pauschenwein
Lena PAUSCHENWEIN, Legal Officer, Directorate-General GROW - Internal Market, Industry, Entrepreneurship and SMEs, European Commission, Brussels, Belgium
Lena Pauschenwein is a jurist specialised in intellectual property law and works in the Intangible Economy Unit of the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs (DG GROW) of the European Commission.
Lena holds law degrees from the University of Vienna (Magister iuris) and the University of Glasgow (LLM), both with a focus on intellectual property and technology law. Prior to joining the European Commission in 2021, she worked at the Austrian Supervisory Authority for Collective Management Organisations.

Martin Schmidt

Rainer Friedrich

David Holland
David is a Partner in Carpmaels’ Life Sciences group. He has been leading the firm’s UPC preparations since the early excitement about the new patent system back in 2014. His practice focuses on managing interrelated oppositions and appeals at the EPO, with a particular focus on platform protection and freedom to operate. David regularly supports pan-European litigation with the Carpmaels’ Dispute Resolution team, so he has seen the pros and cons of the current patchwork of national courts first hand. He expects the UPC to provide a valuable forum for disputes as the new system comes to life. David is often asked to share his UPC expertise, both through industry-wide events and also as a guest lecturer at the Industrial Property Course held by the Politecnico di Milano which entitles European patent attorneys to act before the UPC.

Isobel Barry

Stephan Kutik

Jules Fabre

Robin Ellis

Mike Gilbert
Mike Gilbert is a partner at Marks & Clerk in London. He is an Intellectual Property (IP) lawyer who advises clients in a wide variety of business sectors on issues including litigation and dispute resolution, IP strategy and risk limitation, due diligence projects and commercial and licensing transactions involving IP. His primary focus and expertise, however, lies in life sciences patent litigation where he is considered to be one of the UK’s leading practitioners. He has represented some of the world’s leading biopharmaceutical corporations in complex patent and technical disputes including Genentech, Roche, Chugai, Pfizer, Wyeth, AstraZeneca, MedImmune, Daiichi Sankyo, AbbVie, Amgen and Illumina to name but a few. Mike is well known for his strategic and creative vision and is consistently recommended in various legal directories including the World IP Review, Legal 500, Who's Who Legal and the IAM Patent 1000 guide, which describe him as “always at the top of the pile, especially for pharmaceutical matters”. Mike graduated from Cambridge University in 1989 with a degree in chemical engineering.

Kamleh Nicola
Kamleh J. Nicola is a leading Canadian patent litigator and health regulatory lawyer who has earned a strong reputation in Canada and internationally. She is a partner at Marks & Clerk Canada and is Co-Head of their Litigation Practice. Kamleh’s specialty is working with domestic and multinational pharmaceutical, biopharma and medtech organizations. Her technical competency has attracted some of the world’s best-known brands.
Described by many as tenacious and strategic, she thrives in complex contentious situations across multiple jurisdictions. Kamleh has authored many publications, and presented, on IP, regulatory and compliance subjects focussing on the life science industry

Martina Hufnal

Marc Lauzeral

Takanori Abe
Mr. ABE is an Attorney-at-Law, admitted in both Japan and New York. He is currently a Guest Professor of Osaka University Graduate School of Medicine and formerly a lecturer of The University of Tokyo Graduate School of Medicine and Faculty of Medicine. He is an arbitrator in Japan and sit on various positions in Japanese medical/pharmaceutical societies.
Mr. ABE works in wide areas of international and corporate matters with a focus on intellectual property law and international commerce. The patent litigations that he has participated covers the fields of pharmaceuticals, chemistry, electronics and machinery, which involve advanced technology such as biotechnology, semiconductors, etc., and which are cross-border matters. He has extensive experience on representing and advising multinational and domestic clients in pharmaceutical industry and is currently involved in the drastic battle between brands and also the one between brands and generics. He also has experience in trademark, copyright and unfair competition litigation.
For Mr. ABE’s detail information and activities, please visit www.abe-law.com or email to: [email protected]

Marjan Noor

Charles Tuffreau

Eva Ehlich

Annelie Wunsche
LIFE SCIENCES PATENT ADVISORY BOARD

Fredrik Fredh
Fredrik is a qualified European Patent Attorney and experienced international IP strategist. Having completed academic studies of innovation and entrepreneurship processes, as well as IP law and management, he has a good grasp of various intellectual property rights (IPR).
Thanks to his many years as IP professional in the Pharma and Biotech industry, Fredrik has learnt to use this IPR toolbox to pursue his professional passion; maximizing return on investment for innovation.”

Lorenz Kallenbach
Lorenz Kallenbach is a senior corporate patent counsel in the healthcare division of Merck KGaA. He is responsible for defining and executing the IP strategy for innovator projects. Including the assessment of the IP landscape, coordination of worldwide patent litigation, and portfolio development.
Before joining Merck, Lorenz worked in private practice. He is qualified as a German and European patent attorney.
Lorenz studied biochemistry and received a Ph.D. in the field of epigenetics.

Stephan Kutik

Mathilde Rauline
Mathilde is a European patent attorney, is qualified as a French patent attorney, and is admitted to the Paris bar.
She is head of Greater Europe patent litigation at Sanofi, after having been a patent litigator in private practice (mostly in the pharmaceutical field), and a patent attorney in the industry (Sanofi, Nestlé).
She has extensive experience in pharmaceutical and life-science patent litigation in France, at the EPO, in Europe, and in Eurasia.
Her expertise also comprises contractual matters, settlements, regulatory aspects, and the SPC regulation.

Christof Bull

Alexandra Moulson
Alex is an experienced leader and strategist with a broad background in marketing, product development, business development, portfolio management, and launch.
She has over 18 years of experience in pharmaceuticals, 8 years originators, 8 years biosimilars, and 2 years generics. Alex is British, with Biochemistry and MBA degrees.
Working backward, following her MBA, Alex was at McKinsey (reaching Associate Principal), at Morphosys was the Director for Business Development and at Sandoz brought a rituximab biosimilar to market and later led the Strategy Department for Sandoz. She is currently the Chief Development Officer for Polpharma Biologics.

Mike Cottler

Dr. Leslie Fischer
Leslie Fischer is a Principal Patent Attorney at Sandoz, who focuses on global IP strategy for biosimilars. Before joining Sandoz, Leslie was a patent attorney at Novartis Pharmaceuticals, where she worked for over a decade developing global patent portfolios for biologicals. Before joining the Novartis group, Leslie was an associate at Fitzpatrick Cella (NY) (now Venable). Leslie holds a J.D. from Rutgers University and a Ph.D. in Biochemistry from Thomas Jefferson University. Her scientific work appears in JCB, JBC, and Osteoarthritis & Cartilage. She speaks frequently at patent-related events and is an adjunct professor at Seton Hall Law School.

Ewan Nettleton
2023 PARTNERS
PLATINUM PARTNERS
Carpmaels & Ransford
Website: https://www.carpmaels.com/
Carpmaels & Ransford LLP is a leader in the European IP market, having driven innovation in the industry for over 200 years. The firm advises clients on all aspects of intellectual property, including drafting, filing and prosecuting patent and trademark applications; drafting and negotiating licence agreements and other commercial IP agreements; advising on the transfer of property rights; assisting clients with patent restoration matters; and conducting enforcement and revocation litigation.
The firm has one of Europe’s largest IP teams serving blue-chip clients across the globe, including Johnson & Johnson, Bristol Myers Squibb, Novartis, Ionis Pharmaceuticals, Mars, Gilead, Raytheon, Regeneron, Takeda, Allergan and Xeros. The firm’s attorneys have considerable technical knowledge, bringing together experience from industry-leading companies, academic research at leading universities and extensive patent expertise in the areas of pharmaceuticals, biotechnology, engineering, tech, chemistry, materials, supplementary protection certificates and information and communication technologies and standards.
Through its fully integrated dispute resolution and transactions teams, the firm is able to provide a holistic service to clients which supports their IP needs from inception to commercialisation. The dispute resolution team, made up of experienced solicitors, barristers and patent attorney litigators, represents clients at all levels of the European Patent Office. The team is also adept at conducting enforcement litigation and revocation actions before the UK Intellectual Property Office and patent, copyright, trademark and other IP litigation in the English courts and the Court of Justice of the European Union, often advising in cases where parallel or related litigation is ongoing in courts across Europe or in the United States.
As a European IP firm with litigators and patent attorneys under one roof, Carpmaels & Ransford is looking forward to offering clients the chance to both obtain UPs using the existing EPO procedure and enforce their patents across Europe in the UPC.
Fish & Richardson
Website: https://www.fr.com/
Few firms have protected more innovative and valuable intellectual property than Fish & Richardson. We work with life sciences companies to protect and maximize the value of their IP so that they may achieve their strategic goals through partnership, licensing, financing, acquisition, and enforcement. The Fish team is comprised of accomplished patent attorneys and agents, many of whom boast Ph.D.s and extensive industry experience. Our clients choose to work with Fish attorneys because of their deep technical backgrounds, their expertise on the latest innovations in the industry, and the breadth of their experience working with life sciences companies of every size and in every field.
Pinsent Masons
Website: https://www.pinsentmasons.com/
Pinsent Masons international Life Sciences practice is one of the best in Europe.
Their team, comprising more than 100 sector specialists, many of whom are leading individuals in their field with relevant scientific degrees (some to Ph.D.) and experience, drawn from industry, is dedicated to helping their clients continue to develop cutting-edge strategies that use the law as a business enabler to positively impact their bottom line.
The team acts for businesses globally on complex market shifting transactions; cutting edge R&D collaboration; partnering and licensing deals; the most high profile, business-critical patent and regulatory litigations; and hugely impactful anti-trust investigations and litigations.
Comprising some of the world’s leading life sciences experts, the team works with senior management and in-house legal teams to navigate complex regulatory environments, develop effective risk management strategies, and spot and convert opportunities.
Schertenleib Avocats
Website: https://schertenleib-avocats.com/en/equipe/denis-schertenleib/
Please visit our website for more information.GOLD PARTNERS
Maiwald Intellectual Property
Website: https://www.maiwald.eu/en/
As one of Germany’s largest and best-known firms in the field of intellectual property (IP), providing optimal services to our clients is of paramount importance to us. Our team comprising about 250 people in Munich and Düsseldorf works closely with each other and with foreign associates, always with an eye to the client’s particular needs, regardless of the particular industry or type of company, whether start-up, medium-sized firm or large corporation, in Germany and worldwide. We at Maiwald will do everything to ensure that all your IP matters are handled with competence and commitment.
You can rely on Maiwald’s wide-ranging expertise. We provide a full range of services covering all aspects of IP law. Our highly qualified patent attorneys and attorneys-at-law unite all of the most important skills one would expect of an interdisciplinary team: sound legal knowledge, business proficiency and a broad range of technical and scientific know-how. And, it goes without saying, absolute professionalism, efficiency and close attention to the needs of each individual client. So you may be assured of receiving the best possible advice on all IP-related issues based on our proven competence and industry knowledge.
Marks & Clerk
Website: https://www.marks-clerk.com/
Marks & Clerk is an international law firm specialising in intellectual property (IP) law. With a vast network of over 650 professionals across the world, including a qualified team of experienced patent and trademark associates, the firm offers comprehensive technical expertise covering all aspects of intellectual property matters, such as patents, trademarks, designs and copyright. Its services encompass worldwide protection, portfolio management, strategic advice, commercial guidance, licensing, enforcement, clearance and searches, validity and infringement opinions, due diligence and litigation. Operating through a network of offices in Canada, Europe and Asia, Marks & Clerk consistently delivers high-quality, seamless and cost-effective services to clients both locally and globally.
Reddie & Grose
Website: https://www.reddie.co.uk/
Reddie and Grose is a European IP firm with offices in London, Munich and Cambridge. Our life sciences team is made up of specialist hubs that allow us to offer tailored services across the entire IP spectrum. This blend of specialism and diversity is recognised as one of our key strengths.
Our biotech hub is based out of our Cambridge office and has decades of experience taking clients from university spin-off to IPOs, as well as being experts in obtaining plant variety protection. Our London team specialises in managing the global patent portfolios and supplementary protection certificate strategies of multi-national companies based in the UK and Europe. In Munich, the team focuses on contentious pharmaceutical cases, regularly representing clients in EP opposition proceedings and advising on European product launch and litigation strategies.
Combining all this knowledge ensures that are clients will always benefit from rounded, commercially aware, advice of the highest standard.
Venable LLP
Website: https://www.venable.com/
Venable LLP is an American Lawyer Global 100 law firm headquartered in Washington, DC that serves as primary counsel to a worldwide clientele of large and mid-sized organizations, nonprofits, and high-net-worth entrepreneurs and individuals. With more than 850 professionals across the country, including California, Delaware, Florida, Illinois, Maryland, New York, Virginia, and Washington, DC, the firm strategically advances its clients' objectives in the U.S. and around the globe. Venable advises clients on a broad range of business and regulatory law, legislative affairs, complex litigation, and the full range of intellectual property disciplines. For more information, please visit www.Venable.com.
ASSOCIATE MEDIA PARTNER
CTC Legal Media (Patent Lawyer Magazine)
Website: https://ctclegalmedia.com/
CTC Legal Media are globally renowned publishers of The Trademark Lawyer and The Patent Lawyer Magazines, reporting on core IP matters. Each and every edition is full of exclusive special features including guest interviews with in-house counsel, case comment, and the latest developments in the IP Industry, delivered to a combined hardcopy and digital global readership of over 93,000+ IP professionals.
MEDIA PARTNERS
4IP Council
Website: https://www.4ipcouncil.com/
4iP Council is a European research council dedicated to developing high quality academic insight and empirical evidence on topics related to intellectual property and innovation. Our research is multi-industry and cross sector. We work with academia, policy makers and regulators to facilitate a deeper understanding of the invention process and of technology investment decision-making.
CEE Legal Matters
Website: https://ceelegalmatters.com/
CEE Legal Matters is a print and online publication for and about lawyers interested and working in Europe's emerging legal markets. CEE Legal Matters features news, interviews, analysis, opinion, and more. We also host conferences and round-tables and produce special reports on fees, salaries, and other subjects of interest to lawyers in the region. Our mission is, simply, to be the go-to source of information about lawyers and legal markets in Central and Eastern Europe.
The Global IP Matrix
Website: https://www.gipmatrix.com/
The Global IP Matrix is the only print and digital IP industry-specific publication authored by legal professionals in the intellectual property sector. Our content is 100% contributed by IP industry legal professionals for professionals in the IP field.
Industry thought leaders provide comprehensive, detailed analysis reports on innovation, IP trends, new legislation, and IP strategy, amongst other topics in the IP spectrum internationally.
We have an unbiased approach, and we welcome thought leaders at all levels to share their knowledge and experience through sharing thought-provoking content.
For more info contact us at - [email protected] or call +44 (0)203 813 045
Global Legal Group
Website: https://www.glgroup.co.uk/
Global Legal Group is an independent digital media company based in central London. Our clients are private practice and in-house lawyers, multinational corporations, and professional services firms in over 190 countries around the world.Founded in 2002, Global Legal Group’s first product was the International Comparative Legal Guides (ICLG) series, which has grown into a world-renowned legal resource that covers the law in more than 192 jurisdictions and across 58 practice areas.Since 2009, GLG has also produced Commercial Dispute Resolution, an online news and print magazine for litigation and arbitration specialists. In 2011, GLG introduced Global Legal Insights, an essential analytical resource detailing current legal issues spanning 16 practice areas, and, in 2014, African Law & Business was unveiled. Since 2012, GLG has also hosted a successful series of conferences and events, including the annual Global Class Actions Symposium, the premier event for international class actions specialists.Our mission is to provide outstanding performance for our clients and partners. We provide the digital technologies and expertise that they need to boost their brand exposure and market reach, as well as access to the world’s leading online network of legal experts. By only partnering with the leading legal and business authorities, we also ensure that the information we provide is topical, enlightening and authoritative, making our products the go-to resource.
JUVE
Website: https://www.juve-patent.com
JUVE has been reporting on the UPC, the European Patent Office and developments at law firms and in-house departments for twenty years – and in English since 2018.
JUVE Patent provides daily news coverage, in-depth reports and annual rankings on the four most important European patent markets.
Patent Lawyer Magazine
Website: https://patentlawyermagazine.com/
Please visit our website for more information.Women's IP World
Website: https://www.womensipworld.com/
The Women's IP World Annual was launched in 2019 to highlight and celebrate the work and achievements of women working in IP, IP Law & innovation globally. Women play significant roles in IP & Innovation that should be recognised and discussed at the highest level.
We endeavour to give women from all over the world (that work in IP Law and innovation) a voice and a platform to showcase their expertise and experiences of working in the industry and receive recognition for their outstanding work and achievements with other like-minded professionals working in these fields.
Our publication has received much attention from international IP organisations like INTA and AIPPI, who have contributed the opening letters to our last two annual editions. Our yearly publication has attracted a cocktail of awe-inspiring women from all over the world who are happy to share their profiles and experience working in the industry with our global audience.
The Women's IP World annual publication is produced only once per year. It is distributed monthly for one year at IP and innovation conferences and exhibitions all over the world. Our magazine is published in a few different formats, including print, digital and now in audio format via iTunes, PodOmatic, Spotify, Audible and Amazon Music for a more unintrusive listening experience.
Women's IP World 2022 presentation - https://www.youtube.com/watch?v=6SgpYU2uWto
Venue
Hilton Munich Park Am Tucherpark 7 80538 Munich
This year's summit will be taking place at:
Hilton Munich Park
Am Tucherpark 7
80538 Munich
Discounted Room Rate: €199 per night - for reservations please click here.
BOOK YOUR PLACE TODAY
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
Registration ends on
— October 13, 2023 —
PARTNER WITH US
Based on your objectives, we can create bespoke packages designed specifically for you – from presenting your expertise on the main stage, to hosting a private dinner. You can partner with us showcase your brand and make valuable new connections. Opportunities predominantly lie in 3 main categories: Thought Leadership, Branding & Networking.
To discuss your objectives and partnership opportunities please contact [email protected].
Interested in a media partnership?
We'd love to hear from you and how we can support one another to connect with the industry. Contact [email protected].
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.